Coyle Financial Counsel’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-324
Closed -$18K 66
2018
Q2
$18K Sell
324
-37
-10% -$2K 0.02% 84
2018
Q1
$23K Buy
+361
New +$23.2K 0.02% 63

Other funds holding BMY

Coyle Financial Counsel's BMY Position: Q3 2018 in Review

Coyle Financial Counsel sold out of Bristol-Myers Squibb (BMY) in Q3 2018, closing a stake of 324 shares — an estimated $18K sold.

Coyle Financial Counsel first reported a position in BMY in Q1 2018 and held it in 2 quarters. The position peaked at $23K in Q1 2018. 1,730 funds tracked by Wall St. Rank hold BMY as of Q3 2018.

  • Coyle Financial Counsel reported no remaining Bristol-Myers Squibb position as of Q3 2018 after selling out during the quarter.
  • Coyle Financial Counsel sold 324 Bristol-Myers Squibb shares in Q3 2018, an estimated $18K.
  • Coyle Financial Counsel first reported a position in Bristol-Myers Squibb in Q1 2018 and held it in 2 quarters.
  • Coyle Financial Counsel's Bristol-Myers Squibb position peaked at $23K in Q1 2018.
  • 1,730 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2018.

Based on Coyle Financial Counsel's 13F filing for Q3 2018, filed 13 Nov 2018.